Skip to main content
Fig. 5 | BMC Pulmonary Medicine

Fig. 5

From: The combination therapy of isomucronulatol 7-O-beta-glucoside (IMG) and CEP-9722 targeting ferroptosis-related biomarkers in non-small cell lung cancer (NSCLC)

Fig. 5

The results of risk score and prognostic genes in NSCLC patients by using scRNA-seq. A The cells were categorized into 7 clusters based on different cell markers. B Scatter plots show the risk score expression distribution in different cell clusters. C The distributions of signature genes in different cell populations in NSCLC

Back to article page